Donor immune cells tested as new weapon against tough childhood cancers
NCT ID NCT03420963
Summary
This early-stage study tested a new combination treatment for children and young adults whose solid tumors had returned or stopped responding to standard therapies. Researchers gave patients chemotherapy followed by immune cells (called NK cells) donated from umbilical cord blood to see if the combination was safe and could fight the cancer. The main goal was to find the safest dose and understand the side effects, as this was a first-in-human trial for this specific approach.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY MALIGNANT SOLID NEOPLASM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.